首页> 外文期刊>Current medicinal chemistry >Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications.
【24h】

Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications.

机译:糖尿病心肌病及其金属硫蛋白的预防:实验证据,可能的机制和临床意义。

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiac failure is a leading cause for the mortality of diabetic patients, in part due to a specific cardiomyopathy, referred to as diabetic cardiomyopathy, which occurs with or without co-existence of vascular diseases. Although several mechanisms responsible for diabetic cardiomyopathy have been proposed, oxidative stress is widely considered as one of the major causes for the pathogenesis of the disease. Thus, a few laboratories are trying to develop antioxidants used to prevent diabetic cardiomyopathy. Metallothioneins (MTs) are cysteine-rich metal-binding proteins with several biological roles including antioxidant property. We and others have indicated the significant cardiac protection of MT against diabetes using cardiac-specific MT-overexpressing transgenic mice and OVE26MT mice (cross-bred of cardiac MT transgenic mice with genetically engineered diabetic OVE26 mice). Several possible mechanisms responsible for MT's cardiac protection from diabetes were revealed. These include MT's important roles in calcium regulation, zinc homeostasis, insulin sensitization, and antioxidant action. Since MT is ubiquitously expressed in mammalian tissues and is highly inducible by a variety of reagents such as zinc, the clinical potential for inducing cardiac MT as an antioxidant by zinc supplementation to prevent various diabetic complications, including cardiomyopathy, has been explored in diabetic animal models and patients. Since zinc has been therapeutically used for several other non-diabetic diseases in clinics, it provides further potential use of zinc for diabetic patients. Therefore, this review will briefly introduce the biochemical features of MT along with its critical roles in redox homeostasis and antioxidant function in the heart, and then discuss the current research on the prevention of diabetic cardiomyopathy by MT with an emphasis on experimental evidence, possible mechanisms, and clinical implications.
机译:心脏衰竭是糖尿病患者死亡的主要原因,部分归因于特定的心肌病,称为糖尿病性心肌病,其在有或没有血管疾病共存的情况下发生。尽管已经提出了引起糖尿病性心肌病的几种机制,但是氧化应激被广泛认为是该疾病的发病机理的主要原因之一。因此,一些实验室正在尝试开发用于预防糖尿病性心肌病的抗氧化剂。金属硫蛋白(MTs)是富含半胱氨酸的金属结合蛋白,具有多种生物学作用,包括抗氧化性能。我们和其他人已经表明,使用心脏特异的过表达MT的转基因小鼠和OVE26MT小鼠(与基因改造的糖尿病OVE26小鼠杂交的心脏MT转基因小鼠),MT对糖尿病具有显着的心脏保护作用。揭示了可能导致MT对糖尿病的心脏保护的几种机制。这些包括MT在钙调节,锌稳态,胰岛素增敏和抗氧化作用中的重要作用。由于MT在哺乳动物组织中普遍表达并且可以被多种试剂(例如锌)高度诱导,因此在糖尿病动物模型中已经探索了通过补充锌来诱导心脏MT作为抗氧化剂来预防各种糖尿病并发症(包括心肌病)的临床潜力。和病人。由于锌已在临床上用于治疗其他几种非糖尿病疾病,因此它为糖尿病患者提供了锌的进一步潜在用途。因此,本综述将简要介绍MT的生化特征及其在心脏中的氧化还原稳态和抗氧化功能中的关键作用,然后重点讨论当前通过MT预防糖尿病性心肌病的研究,重点是实验证据,可能的机制和临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号